Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients

What Was Tested

The paper reports a study of Calcitonin in the context of osteoporosis and bone density, published as a randomized controlled trial.

This study aimed to evaluate the effects of salmon calcitonin, and calcium and vitamin D treatment on bone mineral density, serum and synovial fluid bone formation and resorption markers in patients with osteoporosis.

Who Took Part

The abstract describes 15 patients taking part.

The age groups tagged for this paper are middle-aged adults, both men and women.

The study was completed with twenty-five osteoporosis patients divided into two groups: The 15 patients comprising Group I (1 male and 14 females; mean age: 67.0±12.0) were administered calcitonin treatment in addition to calcium and vitamin D.

The 10 patients in Group II (3 males and 7 females; mean age 68.0±16.0) were administered calcium and vitamin D only.

How the Study Was Run

In design terms this was a randomized study.

The patients were allocated by chance, so the Calcitonin group and the comparison group should start out alike.

Serum and synovial fluid calcium phosphorus, alkaline phosphatase, calcitonin, C-telopeptide (CTx), N-telopeptide (NTx) and sialoprotein levels, and bone densitometries were determined at the beginning and at the end of one year of treatment.

What Was Measured

The subject headings attached to it are Biomarkers, Bone Density, Bone Density Conservation Agents, Calcitonin, Osteogenesis, Osteoporosis and Posture.

What This Means in Plain Language

The paper is a randomized study of Calcitonin in 15 patients in people with osteoporosis and bone density.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 9 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2015 (Acta orthopaedica et traumatologica turcica), a journal based in Turkey.

More context: the Calcitonin compound page, Osteoporosis and bone density research.